We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Investigating the potential neuroprotective benefits of taurine and Dihydrotestosterone and Hydroxyprogesterone levels in SH-SY5Y cells.
- Authors
Almohaimeed, Hailah M.; Almars, Amany I.; Alsulaimani, Fayez; Basri, Ahmed M.; Althobaiti, Norah A.; Albalaw, Aishah E.; Alsharif, Ifat; Al Abdulmonem, Waleed; Hershan, Almonther Abdullah; Soliman, Mona H.
- Abstract
Background: Taurine, an amino acid abundantly found in the brain and other tissues, has potential neuroprotective properties. Alzheimer's disease (AD) is a commonly occurring type of dementia, which becomes more prevalent as people age. This experiment aimed to assess the neuroprotective effects of taurine on SH-SY5Y cells by examining its impact on Dihydrotestosterone (DHT), Dihydroprogesterone (DHP), as well as the expression of miRNA-21 and miRNA-181. Methods: The effects of various taurine concentrations (0.25, and 0.75 mg/mL), and LPS (0.1, and 12 mg/mL) on the SH-SY5Y cell line were assessed using the MTT assay. The levels of DHT and DHP were quantified using an ELISA kit. Additionally, the expression levels of miRNA-181 and miRNA-21 genes were examined through Real-Time PCR analysis. Results: The results of the MTT assay showed that treatment with taurine at concentrations of 0.25, and 0.75 mg/mL reduces the toxicity of LPS in SHSY5Y cells. ELISA results indicated that taurine at a concentration of 0.25, and 0.75 mg/mL significantly elevated DHT and DHP hormones in the SH-SY5Y cell line compared to the untreated group (p < 0.01). The expression levels of IL-1β and IL-6 were decreased under the influence of LPS in SH-SY5Y cells after taurine treatment (p < 0.01). Gene expression analysis revealed that increasing taurine concentration resulted in heightened expression of miRNA-181 and miRNA-21, with the most significant increase observed at a concentration of 0.75 mg/mL (p < 0.001). Conclusion: Our study findings revealed that the expression of miRNA-181 and miRNA-21 can be enhanced by taurine. Consequently, exploring the targeting of taurine, miRNA-181, and miRNA-21 or considering hormone therapy may offer potential therapeutic approaches for treating AD or alleviating severe symptoms. Nonetheless, in order to fully comprehend the precise mechanisms involved, additional research is required.
- Subjects
RNA metabolism; THERAPEUTIC use of testosterone; PROGESTERONE; NEUROPROTECTIVE agents; ALZHEIMER'S disease; DATA analysis; RESEARCH funding; ENZYME-linked immunosorbent assay; POLYMERASE chain reaction; DESCRIPTIVE statistics; CELL lines; GENE expression; CYTOTOXINS; AGING; STATISTICS; ANALYSIS of variance; DATA analysis software; ALKANES; PHARMACODYNAMICS
- Publication
Frontiers in Aging Neuroscience, 2024, p1
- ISSN
1663-4365
- Publication type
Article
- DOI
10.3389/fnagi.2024.1379431